Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.

Erythropoiesis requires erythropoietin (Epo) and stem cell factor (SCF) signaling via their receptors EpoR and c-Kit. EpoR, like many other receptors involved in hematopoiesis, acts via the kinase Jak2. Deletion of EpoR or Janus kinase 2 (Jak2) causes embryonic lethality as a result of defective erythropoiesis. The contribution of distinct EpoR/Jak2-induced signaling pathways (mitogen-activated protein kinase, phosphatidylinositol 3-kinase, signal transducer and activator of transcription 5 [Stat5]) to functional erythropoiesis is incompletely understood. Here we demonstrate that expression of a constitutively activated Stat5a mutant (cS5) was sufficient to relieve the proliferation defect of Jak2(-/-) and EpoR(-/-) cells in an Epo-independent manner. In addition, tamoxifen-induced DNA binding of a Stat5a-estrogen receptor (ER)* fusion construct enabled erythropoiesis in the absence of Epo. Furthermore, c-Kit was able to enhance signaling through the Jak2-Stat5 axis, particularly in lymphoid and myeloid progenitors. Although abundance of hematopoietic stem cells was 2.5-fold reduced in Jak2(-/-) fetal livers, transplantation of Jak2(-/-)-cS5 fetal liver cells into irradiated mice gave rise to mature erythroid and myeloid cells of donor origin up to 6 months after transplantation. Cytokine- and c-Kit pathways do not function independently of each other in hematopoiesis but cooperate to attain full Jak2/Stat5 activation. In conclusion, activated Stat5 is a critical downstream effector of Jak2 in erythropoiesis/myelopoiesis, and Jak2 functionally links cytokine- with c-Kit-receptor tyrosine kinase signaling.

[1]  P. Sathyanarayana,et al.  EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts. , 2007, Blood.

[2]  P. Sathyanarayana,et al.  Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. , 2007, Blood.

[3]  D. Kent,et al.  Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells. , 2007, Blood.

[4]  L. Hennighausen,et al.  Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. , 2007, Genes & development.

[5]  C. Pecquet,et al.  Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. , 2007, Blood.

[6]  J. Ihle,et al.  Two Domains of the Erythropoietin Receptor Are Sufficient for Jak2 Binding/Activation and Function , 2006, Molecular and Cellular Biology.

[7]  M. Farrar,et al.  Constitutive Activation of STAT5 Supersedes the Requirement for Cytokine and TCR Engagement of CD4+ T Cells in Steady-State Homeostasis1 , 2006, The Journal of Immunology.

[8]  I. Weissman,et al.  Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. , 2006, The American journal of pathology.

[9]  L. Hennighausen,et al.  Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. , 2006, Blood.

[10]  B. Habermann,et al.  Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR , 2006, Oncogene.

[11]  D. Wojchowski,et al.  Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. , 2006, The Journal of clinical investigation.

[12]  W. Vainchenker,et al.  Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells. , 2005, Blood.

[13]  P. Hammerman,et al.  Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. , 2005, Blood.

[14]  Mario Cazzola,et al.  A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.

[15]  Stefan N. Constantinescu,et al.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.

[16]  Sandra A. Moore,et al.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.

[17]  P. Campbell,et al.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.

[18]  D. Barber,et al.  Turning cells red: signal transduction mediated by erythropoietin. , 2005, Trends in cell biology.

[19]  J. Cheung,et al.  Erythropoietin-modulated calcium influx through TRPC2 is mediated by phospholipase Cgamma and IP3R. , 2004, American journal of physiology. Cell physiology.

[20]  Mark J. Murphy,et al.  c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. , 2004, Genes & development.

[21]  C. Deng,et al.  Inactivation of Stat5 in Mouse Mammary Epithelium during Pregnancy Reveals Distinct Functions in Cell Proliferation, Survival, and Differentiation , 2004, Molecular and Cellular Biology.

[22]  K. Akashi,et al.  Mouse Development and Cell Proliferation in the Absence of D-Cyclins , 2004, Cell.

[23]  G. Morrone,et al.  Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation , 2004, The Journal of experimental medicine.

[24]  A. Sytkowski,et al.  Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. , 2004, Blood.

[25]  H. Beug,et al.  Control of Erythropoiesis by Erythropoietin and Stem Cell Factor: A Novel Role for Bruton’s Tyrosine Kinase , 2004, Cell cycle.

[26]  C. Couldrey,et al.  Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness. , 2004, Blood.

[27]  H. Neubauer,et al.  JAK2 contributes to the intrinsic capacity of primary hematopoietic cells to respond to stem cell factor. , 2004, Experimental hematology.

[28]  M. Katsuki,et al.  Targeted disruption of oncostatin M receptor results in altered hematopoiesis. , 2003, Blood.

[29]  B. Habermann,et al.  Apoptosis Protection by the Epo Target Bcl-XL Allows Factor-Independent Differentiation of Primary Erythroblasts , 2002, Current Biology.

[30]  T. Clackson,et al.  JAK2, complemented by a second signal from c‐kit or flt‐3, triggers extensive self‐renewal of primary multipotential hemopoietic cells , 2002, The EMBO journal.

[31]  H. Lodish,et al.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.

[32]  H. Lodish,et al.  Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors. , 2001, Blood.

[33]  H. Beug,et al.  Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis , 2001, Oncogene.

[34]  J. Ihle,et al.  The distal region and receptor tyrosines of the Epo receptor are non‐essential for in vivo erythropoiesis , 2001, The EMBO journal.

[35]  H. Beug,et al.  Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  L. Hennighausen,et al.  Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. , 2000, Development.

[37]  J. Marine,et al.  A small amphipathic α‐helical region is required for transcriptional activities and proteasome‐dependent turnover of the tyrosine‐phosphorylated Stat5 , 2000, The EMBO journal.

[38]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[39]  J. Darnell,et al.  The Significance of Tetramerization in Promoter Recruitment by Stat5 , 1999, Molecular and Cellular Biology.

[40]  A. Elefanty,et al.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Johnston,et al.  A conditionally active form of STAT6 can mimic certain effects of IL-4. , 1998, Journal of immunology.

[42]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[43]  J. Marine,et al.  Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.

[44]  A. Cumano,et al.  Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis , 1998, Cell.

[45]  R. Moriggl,et al.  Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells , 1997, Molecular and cellular biology.

[46]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Lodish,et al.  Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Heinrich,et al.  Comparison of the effects of insulin, PDGF, interleukin-6, and interferon-g on glucose transport in 3T3-L1 cells: lack of cross-talk between tyrosine kinase receptors and JAK/STAT pathways , 1996, Diabetologia.

[49]  B. Groner,et al.  Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype , 1996, Molecular and cellular biology.

[50]  D. Longo,et al.  JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor. , 1996, Blood.

[51]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[52]  H. Lodish,et al.  Interaction of the erythropoietin and stem-cell-factor receptors , 1995, Nature.

[53]  K. Muta,et al.  Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. , 1995, Blood.

[54]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[55]  A. Bernstein,et al.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. , 1989, Genes & development.

[56]  H. Beug,et al.  Expansion and differentiation of immature mouse and human hematopoietic progenitors. , 2005, Methods in molecular medicine.

[57]  E. Wagner,et al.  Stat5 tetramer formation is associated with leukemogenesis. , 2005, Cancer cell.

[58]  K. Kaushansky.  On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. , 2005, Blood.

[59]  H. Beug,et al.  A Novel Way to Induce Erythroid Progenitor Self Renewal: Cooperation of c-Kit with the Erythropoietin Receptor , 1999, Biological chemistry.

[60]  Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation , 2022 .